markets

Windward Bio Debuts on Nasdaq, Shares Surge 68% on IPO Day

Summarized from All Financial Services & Investing

Clinical-stage biotech Windward Bio priced its IPO at $17 per share and closed its first trading day at $28.50 on Nasdaq.

Windward Bio Debuts on Nasdaq, Shares Surge 68% on IPO Day

Windward Bio, a clinical-stage biotechnology company backed by Qiming Venture Partners, made its public market debut on Nasdaq on November 13, 2026, under the ticker symbol WWB, the Shanghai-based firm announced.

The company priced its initial public offering at $17.00 per share. By the close of its first trading session, shares had climbed to $28.50, representing a gain of roughly 68 percent from the offering price — a strong opening-day performance by any measure in the current biotech IPO environment.

Read more Leverage Shares Launches 2x Long Anthropic ETF as ANT Debuts on Nasdaq →

Windward Bio focuses on immunology, a therapeutic area that has attracted sustained investor interest as drug developers pursue treatments targeting immune system dysfunction across a range of diseases. The company's listing adds to a pipeline of biotech firms seeking U.S. public market access through Nasdaq.

Qiming Venture Partners, a prominent venture capital firm with deep roots in China's technology and life sciences sectors, holds a portfolio stake in Windward Bio. The firm's backing lends the IPO additional credibility among institutional investors evaluating early-stage biotech risk.

The debut signals continued appetite for clinical-stage biotechnology offerings on U.S. exchanges, even as broader market conditions have been uneven for growth-oriented listings. Continue reading at All Financial Services & Investing.

Frequently Asked Questions

Q.What price did Windward Bio set for its IPO?

Windward Bio priced its initial public offering at $17.00 per share on Nasdaq.

Q.What is Windward Bio's Nasdaq ticker symbol?

Windward Bio trades on Nasdaq under the ticker symbol WWB.

Q.Who is the venture capital backer behind Windward Bio?

Windward Bio is a portfolio company of Qiming Venture Partners, a venture capital firm active in technology and life sciences.

More in markets →